{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:49:45Z","timestamp":1761749385499,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.path.2019.03.014","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:13:08Z","timestamp":1558609988000},"page":"709-718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Challenges in the Diagnosis of Gray Zone Lymphomas"],"prefix":"10.1016","volume":"12","author":[{"given":"Kyle","family":"Parker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish","family":"Venkataraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2008","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","key":"10.1016\/j.path.2019.03.014_bib1"},{"year":"2017","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues (Revised 4th edition)","key":"10.1016\/j.path.2019.03.014_bib2"},{"issue":"Suppl 5","key":"10.1016\/j.path.2019.03.014_bib3","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1093\/annonc\/9.suppl_5.S31","article-title":"Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma)","volume":"9","author":"Rudiger","year":"1998","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.path.2019.03.014_bib4","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":"Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma","volume":"29","author":"Traverse-Glehen","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2019.03.014_bib5","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3324\/haematol.2010.033167","article-title":"Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma","volume":"96","author":"Eberle","year":"2011","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.path.2019.03.014_bib6","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/modpathol.2011.116","article-title":"Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations","volume":"24","author":"Eberle","year":"2011","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.path.2019.03.014_bib7","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ajh.24082","article-title":"Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort","volume":"90","author":"Evens","year":"2015","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.path.2019.03.014_bib8","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1182\/blood-2014-03-564906","article-title":"A\u00a0prospective study of mediastinal gray-zone lymphoma","volume":"124","author":"Wilson","year":"2014","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.path.2019.03.014_bib9","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1182\/bloodadvances.2017009472","article-title":"Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL","volume":"1","author":"Pilichowska","year":"2017","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.path.2019.03.014_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/PAS.0000000000001198","article-title":"Gray-zone lymphoma between cHL and large B-cell lymphoma: a histopathologic series from the LYSA","volume":"43","author":"Sarkozy","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2019.03.014_bib11","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","article-title":"EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment","volume":"126","author":"Nicolae","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.path.2019.03.014_bib12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/his.13100","article-title":"Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases","volume":"70","author":"Elsayed","year":"2017","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.path.2019.03.014_bib13","first-page":"211","article-title":"Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France","volume":"2","author":"Quintanilla-Martinez","year":"2009","journal-title":"J\u00a0Hematop"},{"issue":"10","key":"10.1016\/j.path.2019.03.014_bib14","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1182\/blood.V94.10.3567.422k06_3567_3575","article-title":"The MAL gene is expressed in primary mediastinal large B-cell lymphoma","volume":"94","author":"Copie-Bergman","year":"1999","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.path.2019.03.014_bib15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/PAI.0000000000000236","article-title":"Distinguishing classical Hodgkin lymphoma, gray zone lymphoma, and large B-cell lymphoma: a proposed scoring system","volume":"24","author":"O'Malley","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"5","key":"10.1016\/j.path.2019.03.014_bib16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/ejh.13033","article-title":"Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma","volume":"100","author":"Tanaka","year":"2018","journal-title":"Eur J Haematol"},{"issue":"10","key":"10.1016\/j.path.2019.03.014_bib17","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1097\/PAI.0000000000000615","article-title":"Dendritic cell markers and PD-L1 are expressed in mediastinal gray zone lymphoma","volume":"26","author":"Pelland","year":"2018","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"10","key":"10.1016\/j.path.2019.03.014_bib18","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood-2002-05-1548","article-title":"Nodular sclerosing Hodgkin disease: new grading predicts prognosis in intermediate and advanced stages","volume":"101","author":"von Wasielewski","year":"2003","journal-title":"Blood"},{"issue":"8435","key":"10.1016\/j.path.2019.03.014_bib19","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0140-6736(85)91736-2","article-title":"Review of British National Lymphoma Investigation studies of Hodgkin's disease and development of prognostic index","volume":"1","author":"Haybittle","year":"1985","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.path.2019.03.014_bib20","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/00000478-200211000-00008","article-title":"T-cell\/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells","volume":"26","author":"Lim","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"18","key":"10.1016\/j.path.2019.03.014_bib21","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","article-title":"Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma","volume":"117","author":"Dojcinov","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.path.2019.03.014_bib22","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1309\/VD2D-98ME-MB3F-WH34","article-title":"Composite angioimmunoblastic T-cell lymphoma and diffuse large B-cell lymphoma: a case report and review of the literature","volume":"118","author":"Xu","year":"2002","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.03.014_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ajcp\/112.2.241","article-title":"CD30 expression is common in mediastinal large B-cell lymphoma","volume":"112","author":"Higgins","year":"1999","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.path.2019.03.014_bib24","doi-asserted-by":"crossref","first-page":"e0126615","DOI":"10.1371\/journal.pone.0126615","article-title":"The expression of CD30 based on immunohistochemistry predicts inferior outcome in patients with diffuse large B-cell lymphoma","volume":"10","author":"Hao","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.path.2019.03.014_bib25","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/bjh.13085","article-title":"CD30 expression in de novo diffuse large B-cell lymphoma: a population-based study from British Columbia","volume":"167","author":"Slack","year":"2014","journal-title":"Br J Haematol"},{"issue":"14","key":"10.1016\/j.path.2019.03.014_bib26","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood-2012-10-461848","article-title":"CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.path.2019.03.014_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2014-05-575092","article-title":"Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?","volume":"125","author":"Dunleavy","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.path.2019.03.014_bib28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3324\/haematol.2016.152256","article-title":"Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association","volume":"102","author":"Sarkozy","year":"2017","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.path.2019.03.014_bib29","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2141.2004.04964.x","article-title":"Adverse prognostic significance of CD20 positive Reed\u2013Sternberg cells in classical Hodgkin's disease","volume":"125","author":"Portlock","year":"2004","journal-title":"Br J Haematol"},{"issue":"15","key":"10.1016\/j.path.2019.03.014_bib30","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","article-title":"Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma","volume":"368","author":"Dunleavy","year":"2013","journal-title":"N\u00a0Engl J Med"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:40:05Z","timestamp":1761748805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918119300315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1875918119300315"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2019.03.014","relation":{},"ISSN":["1875-9181"],"issn-type":[{"type":"print","value":"1875-9181"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in the Diagnosis of Gray Zone Lymphomas","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2019.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}